{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002384","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"EGAX00001272584","attributes":{"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["7 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY":["H3K4me3"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ?l"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ?g"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["100.000 cells = 6,7 ?l"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked 10 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Histone protocol: 100.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["204"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor NGS (UCD-600)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/1532CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"444K","NAME":"S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/1532CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"b19cee45f01a60677a340d8fa33bfc5a"},{"FORMAT":"BED","SIZE":"556K","NAME":"S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/1532CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"52205388bc3c28d5ada024af2631edc3"},{"FORMAT":"Text","SIZE":"650K","NAME":"S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/1532CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150527.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"a0e96d35c09becf0714203889cef5052"},{"FORMAT":"bigWig","SIZE":"1.1G","NAME":"S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150529.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/1532CLL/Chronic_Lymphocytic_Leukemia/ChIP-Seq/NCMLS/S00GPRH1.ERX712657.H3K4me3.bwa.GRCh38.20150529.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"fcf8fd218d505262aab2de23efcc134b"}],"dataset_id":"EGAD00001002384","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"1532CLL","sample_barcode":"S00GPRH1","attributes":{"DISEASE":["Chronic Lymphocytic Leukemia"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0023434"}],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"UBERON_0013756"}],"GENDER":["male"],"DONOR_ID":["1532CLL"],"DONOR_HEALTH_STATUS":["Chronic Lymphocytic Leukemia"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["85 - 90"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"TISSUE_TYPE":["venous blood"],"BIOMATERIAL_TYPE":["Primary Tissue"],"SUBJECT_ID":["1532CLL"],"DONOR_SEX":["Male"],"DONOR_ETHNICITY":["NA"],"COLLECTION_METHOD":["Venipuncture"],"TISSUE_DEPOT":["NA"]},"SAMPLE_ID":"EGAN00001265750","SAMPLE_DESCRIPTION":"Chronic Lymphocytic Leukemia"}}